In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma

  1. Ocio, E.M.
  2. Vilanova, D.
  3. Atadja, P.
  4. Maiso, P.
  5. Crusoe, E.
  6. Fernández-Lázaro, D.
  7. Garayoa, M.
  8. San-Segundo, L.
  9. Hernández-Iglesias, T.
  10. de Álava, E.
  11. Shao, W.
  12. Yao, Y.-M.
  13. Pandiella, A.
  14. San-Miguel, J.F.
Revue:
Haematologica

ISSN: 0390-6078,  1592-8721

Année de publication: 2010

Volumen: 95

Número: 5

Pages: 794-803

Type: Article

DOI: 10.3324/HAEMATOL.2009.015495 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus